Background. Risk factors and outcomes of bronchial stricture after lung transplantation are not well defined. An association between acute rejection and development of stricture has been suggested in small case series. We evaluated this relationship using a large national registry.
Methods. All lung transplantations between April 1994 and December 2008 per the United Network for Organ Sharing (UNOS) database were analyzed. Generalized linear models were used to determine the association between early rejection and development of stricture after adjusting for potential confounders. The association of stricture with postoperative lung function and overall survival was also evaluated.
Results. Nine thousand three hundred thirty-five patients were included for analysis. The incidence of stricture was 11.5% (1,077/9,335), with no significant change in incidence during the study period (P [ 0.13). Early rejection was associated with a significantly greater incidence of stricture (adjusted odds ratio [AOR], 1.40; 95% confidence interval [CI], 1.22-1.61; p < 0.0001). Male sex, restrictive lung disease, and pretransplantation requirement for hospitalization were also associated with stricture. Those who experienced stricture had a lower postoperative peak percent predicted forced expiratory volume at 1 second (FEV 1 ) (median 74% versus 86% for bilateral transplants only; p < 0.0001), shorter unadjusted survival (median 6.09 versus 6.82 years; p < 0.001) and increased risk of death after adjusting for potential confounders (adjusted hazard ratio 1.13; 95% CI, 1.03-1.23; p [ 0.007).
Conclusions. Early rejection is associated with an increased incidence of stricture. Recipients with stricture demonstrate worse postoperative lung function and survival. Prospective studies may be warranted to further assess causality and the potential for coordinated rejection and stricture surveillance strategies to improve postoperative outcomes.
(Ann Thorac Surg 2013;96:1008-18) Ó 2013 by The Society of Thoracic Surgeons T he number of lung transplant procedures has continued to increase each year, with more than 3,200 transplants performed worldwide in 2009 [1] . Airway complications are an important limitation to successful lung transplantation, with bronchial stricture (referred to as "stricture") as the most common manifestation in most series [2] [3] [4] [5] [6] . Despite the improvements in surgical technique and immunosuppression strategies, the incidence of stricture after lung transplantation in the modern era has been reported between 5% and 30%, with up to a 40% decrease in 5-year survival compared with patients without airway complications [7] [8] [9] .
The mechanism by which stricture may arise remains speculative [2, 10] . Given its overall low prevalence, the implications of this condition developing and the associated risk factors are not well defined [2, 3, 8, 10] . Anecdotal reports from small series suggest a tendency of higher grades of acute cellular rejection before and at the time of bronchial stenosis [2, 5, 6] . To date, there has not been a large multicenter longitudinal analysis to assess the association between early acute rejection and the development of bronchial stricture after transplantation. Our main objective was to evaluate this relationship using a cohort of all lung transplantations performed in the United States and reported to the Organ Procurement and Transplantation Network (OPTN). We hypothesized that recipients with early acute rejection would manifest a higher incidence of stricture. As a secondary assessment, we investigated trends in the development of stricture, as well as the association of stricture with postoperative lung function and overall survival in this population-based analysis.
Patients and Methods
The Institutional Review Board at Duke University Medical Center approved this study.
Data Source
The United Network for Organ Sharing (UNOS) Standard Transplant Analysis and Research files, which contain data regarding every organ donation and transplant event occurring in the United States since October 1, 1987, were used for this analysis [11] . Data are compiled from individual centers and entered by trained data entry personnel, with quality assurance controls in place including electronic data validation systems and on-site audits of participating institutions [12] . The dataset used for the current study comprises a prospectively collected open cohort of lung transplantations performed between October 1987 and December 2011, with follow-up through March 2012.
Study Design
We performed a retrospective cohort analysis of all adult US lung transplantations as recorded in the UNOS/ OPTN database. The study period ranged from April 1994, when recording of stricture information began, through December 2008 to allow a minimum of 3 years' follow-up time to capture stricture incidence and resulting outcomes. To be included in the study, patients had to have a follow-up visit after transplantation documenting the presence or absence of stricture, which is a yes/no field on the "Adult Thoracic Transplant Recipient FollowUp Worksheet" (Office of Management and Budget approved form No. 0915-0157). This form is generated 6 months after transplantation and on the anniversary of transplantation thereafter. Patients with unknown or missing stricture information were excluded. Additional exclusion criteria were patients undergoing multivisceral transplantation (other than heart-lung), recipients of a third lung transplant, pediatric recipients, and lobar or en bloc double-lung transplant recipients.
The primary predictor variable for our analysis was the presence or absence of an early acute rejection (defined as rejection requiring treatment within 1 year of transplantation), and as such, patients were excluded if this information was missing or unknown. Covariates analyzed included age, sex, race (white, black, Hispanic, Asian, other/unknown), primary diagnosis (obstructive disease, restrictive disease, cystic fibrosis/bronchiectasis, pulmonary hypertension, graft failure [for repeated transplantation], or other), type of transplant (bilateral sequential, single lung, combined heart/lung), transplant center volume (quantified as a continuous variable representing the total number of lung transplants performed by a given center during the study period), year of transplantation, chronic steroid use before transplantation, medical condition preceding transplantation (nonhospitalized, hospitalized, intensive care), requirement of life support at the time of transplantation (ventilator, extracorporeal membrane oxygenation, intravenous inotropic agents, intraaortic balloon pump, or inhaled nitric oxide), ventilator dependence at the time of transplantation, days on the waiting list, allograft ischemic time (for bilateral transplantation, this was the maximum ischemic time of either lung), and donor characteristics (age, history of diabetes, history of smoking, history of cocaine use, and arterial partial pressure of oxygen [PO 2 ] on inspired oxygen of 100%).
The primary outcome variable was the development of stricture after transplantation. The trend in stricture incidence and proportion receiving endobronchial stenting therapy were also assessed. For patients in whom stricture developed (regardless of predisposing risk factors), a secondary analysis was performed to evaluate postoperative peak forced expiratory volume at 1 second (FEV 1 ) as a percent of the patient's predicted value, unadjusted and adjusted overall survival compared with recipients without stricture.
Sensitivity Analysis
Early infection (defined as any drug-treated infection before discharge) is captured only through January 2007, and therefore these data are missing for a substantial proportion of patients. As a sensitivity analysis of the primary model to assess for a potential confounding effect of early infection, we reran the multivariable logistic regression analysis to include early infection as an additional covariate for risk adjustment for the subset of patients in whom early postoperative infection data was available (n ¼ 7,036 patients).
Statistical Analysis
Baseline characteristics were described for the overall sample. Medians and interquartile range (IQR) of 25th and 75th percentiles were reported for continuous variables, and proportions (frequency, percentage) for discrete variables. Multivariable logistic regression was performed to assess the association between early acute rejection and the development of stricture, after adjusting for patient demographics, comorbidities, underlying diagnosis, technical aspects of the operative procedure, and donor characteristics. Covariates were determined a priori based on variables previously established in the Abbreviations and Acronyms AOR = adjusted odds ratio BMI = body mass index 95% CI = 95% confidence interval FEV 1 = forced expiratory volume at 1 second (as a percent of the patient's predicted value) IQR = interquartile range OPTN = Organ Procurement and Transplantation Network PO 2 = arterial partial pressure of oxygen UNOS = United Network for Organ Sharing literature to represent potential confounders. These covariates were also evaluated for independent association with stricture development. Missing data for donor PO 2 on 100% oxygen (n ¼ 2,222/9,335 [24%]) was imputed using multivariable regression based on the following donor variables: age, sex, body mass index (BMI), smoking status, presence of diabetes, terminal creatinine level, evidence of pulmonary infection, use of inotropic support, left ventricular ejection fraction, and use of diuretics. In a similar manner, missing data for ischemic time (n ¼ 936/ 9,335 [10%]) was imputed based on the predictor variables of distance (in miles) from the donor hospital to the transplant center, procedure type (single, double, or heart/lung), and center volume. For the subset of patients in whom early postoperative infection data were available, multivariable logistic regression was performed in the manner already described, with the addition of early drug-treated infection as a covariate for risk adjustment to assess the sensitivity of the model to this variable.
The trend over time in stricture development was assessed using the Cochran Armitage trend test [13, 14] . This was analyzed for the study population as a whole, as well as separately, analyzing the trend in incidence for high-volume versus low-volume centers using greater than 34 lung transplants per year to distinguish these groups based on previous strata for high-volume centers reported in the literature [15] . The trend in the proportion of bronchial strictures receiving endobronchial stent therapy was evaluated in the same manner. To assess survival of patients with and without stricture, KaplanMeier plots were constructed and compared using the log-rank test [16] . A separate subanalysis was also constructed to assess survival for stricture treated with or without stenting in cases in which stent information was available. Multivariable Cox proportional hazards modeling was used to assess the independent effect of stricture on time to death, adjusting for potential confounders as described earlier. The proportionality assumption was verified for covariates included in the Cox model. Patients undergoing combined heart/lung transplantation were excluded from survival analyses. Multivariable linear regression was used to evaluate the association of stricture with peak postoperative FEV 1 (bilateral lung transplantation only).
A p value less than or equal to 0.05 was used to indicate statistical significance for all comparisons and analyses. Statistical analyses were performed using JMP, version 10.0 (SAS Institute Inc, Cary, NC) and R, version 2.15.1 (R Core Team 2012).
Results
A total of 9,335 patients were included for analysis (median follow-up, 4.6 years). Patients excluded from the final study population are summarized in Fig 1. The baseline recipient characteristics for the entire cohort are shown in Table 1 , and the donor/transplant characteristics are shown in Table 2 . The median age was 55 years (IQR, 44-61 years), with 47.3% (n ¼ 4,417) being women and 87.3% (n ¼ 8,152) being white. Obstructive lung disease was the most common reason for transplantation (42.8% [n ¼ 3,991]). The proportion of patients receiving bilateral lung transplantation was 50.9% (n ¼ 4,750) and those receiving combined heart/lung transplants was 2.4% (n ¼ 223).
The incidence of stricture in our study population across all years was 11.5% (¼ 1,077/9,335), which ranged from a high of 19.4% in 1995 to a low of 9.0% in 2000 and 2001 (Fig 2A) . There was no statistically significant change in stricture incidence over the study period (p ¼ 0.13). When stratified by high-volume versus low-volume centers, there was no significant change in stricture incidence over time for high-volume centers (p ¼ 0.63). Lowvolume centers demonstrated a significant decrease in incidence of stricture (p ¼ 0.01), with a peak incidence of 25.2% and 22.4% in 1995 and 1996, respectively, with the incidence more closely approximating high-volume centers in later years of the study (Fig 2B) . The trend in endobronchial stent therapy also significantly declined over time from a peak of 84.6% in 1998 to a low of 58.1% in 2008 (p ¼ 0.01) (Fig 2C) (information on stenting was available for 1,059 of 1,077 [98.3%] strictures). Information on bronchial stricture formation is reported to UNOS at interval periods, and as such the interval reporting date is known; however, the date of clinical diagnosis of stricture is not specified. Of the 1,077 bronchial strictures reported in the UNOS database, 631 (58.6%) were reported within the first postoperative year (defined as reporting date less than or equal to 395 days after transplantation to allow for a 30-day reporting lag).
Patients who experienced early acute rejection were significantly more likely to also manifest bronchial stricture after adjusting for potential confounders (adjusted odds ratio [AOR]), 1.40; 95% confidence interval [CI], 1.22-1.61; p < 0.0001]) ( Table 3 ). The association between early acute rejection and bronchial stricture development retained equivalent statistical significance in the subset of cases in which early infection data were available for inclusion as a covariate in the multivariable model (p < 0.0001). Several additional covariates independently associated with stricture development were also identified: male sex (AOR, 1.52; 95% CI, 1.33-1.75; p < 0.0001), primary diagnosis other than obstructive lung disease (p < 0.05 for all other diagnosis categories), hospitalization requirement before transplantation (AOR, 1.37; 95% CI 1.05-1.79; p ¼ 0.02), and bilateral transplantation compared with single-lung transplantation (AOR, 1.61; 95% CI, 1.36-1.92; p < 0.0001). Higher center volume was associated with a significant reduction in stricture incidence (AOR per increase in center volume of 10 lung transplants per year, 0.90; 95% CI, 0.87-0.92; p < 0.0001), as was undergoing combined heart/lung transplantation when compared with single-lung transplantation (AOR, 0.33; 95% CI, 0.17-0.63; p < 0.001). Increasing ischemic time was also associated with a decrease in stricture development (AOR per hour increase 0.87; 95% CI, 0.83-0.92; p < 0.0001). Among single-lung transplant recipients, there was no significant difference in the incidence of stricture comparing single right to single left lung transplantation (AOR, 0.98; 95% CI, 0.80-1.19; p ¼ 0.82). History of diabetes in the donor was the only donor characteristic associated with increased incidence of stricture (AOR, 1.51; 95% CI, 1.10-2.07; p ¼ 0.01).
Patients who experienced stricture had a significantly lower unadjusted overall survival compared with patients without stricture (6.1 versus 6.8 years, respectively; p < 0.001) (Fig 3) (patients undergoing combined heart/lung transplantation [n ¼ 223] were excluded from survival analyses). The independent association of stricture with time to death based on multivariable Cox proportional Of the 1,077 patients in our study population who experienced stricture, 703 (65.3%) received a stent, 345 (32.0%) did not undergo stenting, 18 (1.7%) had lack of information to determine the use of stenting as a treatment modality, and 11 (1.0%) were combined heart/lung recipients excluded from survival analyses (4/11 [36.4%] of whom received a stent). For the 1,048 bilateral or single-lung recipients in whom data on stent use were available, the unadjusted survival was significantly lower in the cohort requiring stent placement (p < 0.0001) (Fig 4) . This retained statistical significance based on multivariable adjusted Cox proportional hazard modeling for time to death adjusted for potential 
Comment
Airway complications including bronchial stricture continue to afflict lung transplant recipients and impede successful lung transplantation. In the current study, we provide further insight into this disease process by demonstrating an association between early acute rejection and bronchial stricture formation in the largest series of airway complications yet reported in the literature. The importance of further delineating the underlying mechanisms of this disease is evident by the association of stricture with worse postoperative outcomes represented in our study population and is further underscored by the lack of improvement in stricture incidence over the 15 years analyzed. The proposed pathophysiologic process underlying bronchial stricture formation involves benign hyperplastic granulation tissue as well as intraluminal fibrosis causing airway obstruction [17, 18] . It has been hypothesized that overstimulation of inflammatory mediators and the recruitment of macrophages to the bronchial endothelium contributes to this phenomenon [4, 18, 19] , which may in part explain the association between early rejection and stricture demonstrated by our study results. Additionally, early animal models evaluating histologic changes in recipient bronchi after lung transplantation demonstrated mononuclear cell infiltrates in the membranous and cartilaginous portion of the donor bronchial mucosa in cases of moderate or severe lung rejection [20] . Ruttmann and associates [21] previously reported an increased risk of stricture formation in patients with early rejection; however, their study population was limited to 10 patients with stricture. Several studies have contradicted these findings by demonstrating no relationship between acute rejection episodes and the occurrence of airway complications [10, 22, 23] , although relatively small sample sizes may have limited the ability to detect such a relationship. What also remains unknown is the relative importance of airway versus vascular rejection on the development of airway strictures.
Although this proposed pathophysiologic condition may imply a causal role of rejection in stricture formation, the retrospective nature of our review and the lack of specific diagnosis dates in the data source preclude determination of causality in the current study. Alternatively, the observed association between early rejection and stricture may relate to a common cause for these processes, such as ischemia-reperfusion injury [23] , or to retained secretions after stricture develops, predisposing to inflammation or infection and contributing to rejection [4] . Additionally, the presence of bronchial stricture, either symptomatic or asymptomatic, may lead to increased bronchoscopic surveillance, with increased use of transbronchial biopsy, resulting in an increase in detection of acute rejection.
Several additional variables that have previously been shown to negatively impact postoperative outcomes after lung transplantation were found to be independent predictors of stricture in our study. Male patients had significantly higher incidence of stricture compared with female recipients, which is consistent with several large single-center studies demonstrating inferior outcomes for male recipients [24, 25] ; however, conflicting reports on the impact of sex on lung transplant outcomes exist in the literature [26, 27] . There was no significant interaction between sex and primary diagnosis regarding stricture formation (data not shown), indicating that the impact of sex was independent of underlying disease. Bilateral lung transplantation demonstrated higher risk of bronchial stricture compared with single-lung transplantation, which is not unexpected given the increased number of airways at risk and multiple anastomoses; however, insufficient information is available to delineate the risk specific to the additional anastomoses given lack of specificity in our data source as to anastomotic versus nonanastomotic stricture. The only donor characteristic significantly associated with increased stricture incidence was diabetes history, which has also been associated with postoperative mortality after lung transplantation [28] .
Patients with obstructive lung disease had decreased incidence of stricture complications relative to other diagnoses, which is also consistent with previous reports of outcomes after transplantation in patients with this diagnosis [29] . The decreased stricture incidence with increasing center volume observed in our study population correlates with previous reports of improved lung transplantation outcomes from high-volume centers [15] . Lower incidence of stricture in combined heart/lung recipients may relate to preserved bronchial blood supply during this operation [17, 30] . Surprisingly, our results demonstrated a paradoxical relationship, with increasing ischemic time associated with decreased incidence of stricture complications. Although this could reflect a willingness of transplant centers to travel further for high-quality organs or reflect wider procurement distances for high-volume centers, the association persisted despite adjusting for these potential confounders. Additionally, the level of statistical significance was maintained when records in which the ischemic time was imputed (n ¼ 936/9,335 [10%]) were excluded from the analysis (data not shown). Although counterintuitive, multiple reports in the literature demonstrate similar findings of a paradoxical impact of ischemic time on postoperative outcomes [31] [32] [33] [34] , although reasons for this relationship have not been elucidated. The data source used for this analysis does not differentiate warm versus cold ischemic time, which precludes further analysis of these components of the total ischemic time.
Previous attempts to delineate postoperative outcomes after stricture have been limited by the relative infrequency of this disease process [8] . Our results demonstrate significantly worse postoperative lung function for patients with stricture based on peak percent FEV 1 , as well as shorter survival. Additionally, patients with bronchial stricture who underwent endobronchial stenting had significantly shorter survival than did those without stenting; this retained significance after adjustment for potential confounders. In a single-center series reported by Chhajed [7] , the survival of patients with airway complications needing intervention was lower than survival in patients who did not need intervention; however, those who survived 30 days from intervention had a survival rate that was comparable to that of recipients without airway complications. Further interpretation of the observed shorter survival in endobronchial stent recipients in our study population would require additional detail, including stricture severity, the location and length of the stricture, and duration of stent use, which is unavailable in our data source. Additionally, the potential for selection bias in determining stent recipients would require further evaluation.
These results should be interpreted in the context of the study design. Given the retrospective nature of this review, the potential for unmeasured confounders exists. Additionally, information on the location of the stricture (eg, anastomotic versus distal) or the degree of luminal narrowing was not available for analysis. The date of diagnosis of bronchial stricture and the date of endobronchial stenting were not available in our data source, and as such time-to-event analyses could not be performed for these occurrences. This lack of time point precision also precluded the ability to determine the temporal relationship between early acute rejection and stricture formation. In cases of acute rejection, it is unknown whether bronchoscopy or biopsy, or both, was done for surveillance or symptomatic reasons. Additionally, the ability to adjust for early postoperative infection is limited by the lack of detail in our data source to specify infectious processes that were pulmonary in origin, which has previously been shown to have an association with bronchial stricture [23, 35] .
In conclusion, data from UNOS suggests that early rejection is associated with an increase in the incidence of bronchial stricture. Recipients with stricture demonstrate worse postoperative lung function and survival. Prospective studies may be warranted to further assess causality and the potential for coordinated rejection and stricture surveillance strategies to improve postoperative outcomes.
DISCUSSION
DR JOSHUA ROBERT SONETT (New York, NY): What is the hypothesis? Most of the time we think technical, then I think maybe ischemic or PED or other ischemic for the distal airway, especially sort of the bronchus intermedius. So tell me why you are going to get a bronchial stricture from the acute rejection?
DR CASTLEBERRY: There are a couple of theories on this in the literature, and these are based on small single-center series, but some propose that inflammatory mediators that may be involved in rejection can contribute to the formulation of granulation tissue and fibrosis that results in a stenosis, and there are also some theories that you could have patient-specific characteristics that may predispose them to acute rejection and may also predispose them to the development of fibrosis and granulation tissue that results in airway stricture.
So our hypothesis was that we would see a relationship between early acute rejection and development of stenosis and it may be related to some of these other causes in addition to what has been postulated regarding technical aspects of the operative procedure and the anastomosis. DR SONETT: Would you also take that curve and do it for patients that had acute rejection? These patients included acute rejection and nonacute rejection the first year, right?
DR SONETT: So you could do that curve again with acute rejection in the first year with or without bronchial stricture?
DR CASTLEBERRY: The focus of the current study was first to evaluate a potential association with acute rejection and the development of bronchial stricture and secondly to report the survival implications of developing bronchial stricture regardless of the etiology. The impact of acute rejection on survival has been previously evaluated in the literature, and I agree that would be of interest in the current study cohort; however, that was not within the scope of our analysis.
DR HARTWIG: When you look at acute rejection alone you will see a decrease in survival, but when you look at people who had acute rejection even without strictures, it is equal. DR ASHISH SHAH (Baltimore, MD): Dr Sonett and I are obviously people who use this database quite a bit, and I would warn everybody that when we use these large databases, once you get beyond death, which is a triple-checked end point in the registry, then it gets a little bit murky about data definitions. If you look at, for example, the STS database, the data definitions are very robust; the UNOS database not so much.
I think impact of acute rejection is a little bit of a misleading title. There really is an association there. It leads us to say, well, we should explore this quite a bit, but in my mind I look at this and say, well, we really need to work on this database to get the data definitions to be better, because as Dr Sonett was alluding to, I think there is a spectrum of problems with airways and I think it is unfair to just lump them altogether as stricture.
I really do think that there is a phenotype of patient that is a profibrotic diathesis, and we are doing some research at Hopkins that suggests that there is an actual gene that may be associated with it that also lends itself to a propensity for OB, et cetera.
As we delve into this database more, it's very powerful and it's very useful in that regard, and we've really got to work on, I think, our data definitions.
DR SONETT:
There are subtleties in the definitions in the database and then the actual transition, because we all know at every transplant center, especially busy centers, coordinators are adding somebody every month who has this type of stricture or that type of stricture. I shudder to think about how many data are not really being put in there in an accurate way. It is just impossible.
DR CASTLEBERRY: I think that's a great point, and certainly the tradeoff with a big database such as UNOS is that you can gain power to detect relationships not otherwise possible with data from a single institution. Much of the literature in this area is comprised of small series of 50 patients or less; some report series in the single digits. So certainly the tradeoff, although there are obvious limitations, as you mentioned, is that you gain power to detect relationships that might not otherwise be apparent, and I think the results of this study and others using UNOS really need to be looked at in coordination with smaller, more granular studies from individual centers.
DR CHARLES HOOPES (Lexington, KY): You showed the data that with heart-lung block this phenomenon is much, much less, and I think you really do a disservice to Patterson and the guys that looked at bronchial artery revascularization. I would encourage you to go back and look at Nichols' paper out of Stanford 2 years ago that shows a very clear ringing across the anastomosis with hypoxia as a predictor in the first 2 weeks of progressive BOS and stricture.
We can say that BAR doesn't make a difference, but if you look at that original Danish database, that's still the best, long-term, 10-year absence of BOS ever reported, and that was done back in the '90s.
DR CASTLEBERRY: And the reason we included heart-lung recipients in the cohort was to be able to evaluate exactly that.
DR SHAH: You did say that. Their bronchial arteries aren't revascularized, right? That phenomenon, that revascularization, is a very different technical consideration.
DR HOOPES: Today you are not sewing bronchus, so it's hard to say.
DR SHAH: Yes. It's the trachea that is the anastomosis. My understanding is that they're going to do a trial, is that right?
DR HOOPES: Well, they tried to get a trial off the ground, but it's been very hard, because it's technically demanding. We tried it. They're gone in 2 weeks; they are thrombosed.
But the issue is if you look at Nichols' data, that's okay, because it's really the first 2 weeks to 3 weeks when this phenomenon is being set up. It's the acute hypoxic injury which precipitates all this, and it doesn't really matter, and that has been Patterson's argument, it doesn't matter if they stay patent for the next 18 years. It's an acute phenomenon.
It reverses the techniques which many of us are using and people report, just cutting back the bronchus right up past the secondary carina and sewing it in where it's all being autorevascularized by the pulmonary tissue. So it's not a bronchus sitting in the air, and I think that clearly helps with vascularization.
DR SHAH: Going back, I don't think all these stricture things are the same. I don't think that branching BI is the same thing as you whip the airway back together again. You have got this anastomotic problem; I think that's different. And the other phenomenon that I have noticed, I don't know if anyone else has, is that I have not noticed as much airway complications in CF patients. And I have changed a little bit to do more interrupted stuff. At Duke we ran everything and that's all we ever did, and I've changed, because these airway things drive me crazy, but I have not seen them in the CF patients as much, and I wonder if anyone else has made that observation. You made the observation that restrictive lung diseases seem to have a higher incidence of it. That's why I don't necessarily think that all ischemia is going to be the story here. I think that better classification of these airway problems is going to be the first critical step, because then we could work backwards to figure out which patients have this phenomenon that will be improved by revascularization at the time of their transplant and others who may be better off with other interventions, such as inhaled therapeutics.
DR HOOPES: What numbers are you using then when you consent patients, ie, what their risk of complications are after lung transplant with the airway? Are you saying 11?
DR CASTLEBERRY: The incidence demonstrated here of 11.5%, which, as I mentioned, didn't vary much year to year, is very consistent with what has been reported in the literature from single-center series.
DR SONETT: I think if you go down that road, there are so many complications to transplant, we would be in there for 4 years in each room.
DR HARTWIG: I found 15% to 20%, and that's based on a Cleveland Clinic paper that was written a while back, but I felt that the majority of people that get a stricture don't have to have them addressed. It's just a minor stricture if it's not more than 50%. DR SHAH: We have this great IP group, but I think that they stent a lot of stuff. I think they don't leave a lot of things alone as a result, so that may be the other driver for stenting or not. These guys, I mean, they're amazing. They've kept some people alive with all sorts of topical stuff, cryo. I mean, there's all sorts of junk that they're trying.
